Supernus schedules Q3 2025 earnings release for Nov 4 after market close

SUPERNUS PHARMACEUTICALS, INC.

Financial results to be released after market close on Tuesday, November 4, 2025.
Conference call at 4:30 p.m. ET with CEO Jack Khattar and CFO Tim Dec.
Live webcast available on Supernus investor relations website; replay for 60 days.
No preliminary financial data provided in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.